Carol Miceli | Director, IR |
Jay Luly | President and CEO |
Paul Mellett | CFO |
Nathalie Adda | SVP and Chief Medical Officer |
Brian Abrahams | RBC Capital Markets |
Jay Olson | Oppenheimer |
Paul O'Brien | ROTH Capital |
Liisa Bayko | JMP Securities |
Patrick Trucchio | Berenberg Capital Markets |
Jack Allen | Baird |
Akash Tewari | Wolfe Research |
Ladies and gentlemen thank you for standing by and welcome to the Enanta Pharmaceuticals Fourth Quarter Financial Results Conference Call. At this time all participations are in a listen only mode. After the speakers presentation there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded. [Operator Instructions]